NCT07902817Phase 3Recruiting

A Phase 3 Blinded Study of JADE101 in Participants With Immunoglobulin A Nephropathy

Study sponsor: Jade Biosciences, Inc. · JBIO

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2029-06Estimated
Enrollment · participants480Estimated
Source updated2026-11-03Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source